Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['multiplemyeloma', 'janssen']
we re driven by our patient-centric approach to provide more personalized treatment options to people living with #multiplemyeloma. learn more about the latest data we re presenting at #asco23: 
Official Twitter site of JanssenUS, to inform media about company news.  Tweets by our communications team. Review our guidelines here: https://t.co/WrVM19L6Yn